Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Temporal Bone | 9 | 2020 | 68 | 2.520 |
Why?
|
| Meniere Disease | 4 | 2023 | 14 | 2.190 |
Why?
|
| Mastoid | 5 | 2020 | 17 | 2.090 |
Why?
|
| Ossicular Replacement | 3 | 2021 | 6 | 1.890 |
Why?
|
| Presbycusis | 3 | 2020 | 11 | 1.870 |
Why?
|
| Hearing Loss, Conductive | 5 | 2021 | 18 | 1.860 |
Why?
|
| Tinnitus | 4 | 2016 | 21 | 1.590 |
Why?
|
| Cochlear Implantation | 7 | 2020 | 34 | 1.420 |
Why?
|
| Ear Diseases | 3 | 2017 | 20 | 1.420 |
Why?
|
| Hearing | 4 | 2020 | 57 | 1.370 |
Why?
|
| Ear Canal | 3 | 2014 | 16 | 1.290 |
Why?
|
| Cochlear Implants | 6 | 2019 | 36 | 1.260 |
Why?
|
| Hearing Loss, Sensorineural | 6 | 2020 | 50 | 1.230 |
Why?
|
| Ossicular Prosthesis | 3 | 2020 | 5 | 1.210 |
Why?
|
| Stapes Surgery | 2 | 2021 | 6 | 1.110 |
Why?
|
| Hearing Loss | 3 | 2016 | 62 | 1.060 |
Why?
|
| Ear Neoplasms | 2 | 2017 | 13 | 1.060 |
Why?
|
| Facial Nerve | 2 | 2019 | 34 | 1.010 |
Why?
|
| Otitis Media with Effusion | 2 | 2018 | 6 | 1.010 |
Why?
|
| Eustachian Tube | 2 | 2018 | 9 | 1.000 |
Why?
|
| Temporal Arteries | 2 | 2015 | 9 | 0.970 |
Why?
|
| Cholesteatoma, Middle Ear | 2 | 2015 | 8 | 0.930 |
Why?
|
| Ear, Inner | 2 | 2017 | 33 | 0.930 |
Why?
|
| Endolymphatic Hydrops | 2 | 2023 | 4 | 0.910 |
Why?
|
| Otologic Surgical Procedures | 5 | 2015 | 13 | 0.910 |
Why?
|
| Intraoperative Complications | 2 | 2020 | 185 | 0.810 |
Why?
|
| Audiometry, Pure-Tone | 7 | 2021 | 25 | 0.810 |
Why?
|
| Hearing Aids | 2 | 2013 | 8 | 0.800 |
Why?
|
| Surgical Flaps | 2 | 2015 | 250 | 0.800 |
Why?
|
| Mastoidectomy | 1 | 2020 | 3 | 0.720 |
Why?
|
| Hydroxyapatites | 1 | 2020 | 7 | 0.720 |
Why?
|
| Humans | 52 | 2023 | 89961 | 0.700 |
Why?
|
| Postoperative Complications | 5 | 2020 | 2314 | 0.690 |
Why?
|
| Mucous Membrane | 2 | 2018 | 83 | 0.670 |
Why?
|
| Cholesteatoma | 2 | 2017 | 7 | 0.660 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2019 | 71 | 0.640 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2018 | 25 | 0.630 |
Why?
|
| Cranial Fossa, Middle | 1 | 2018 | 13 | 0.630 |
Why?
|
| Superior Olivary Complex | 1 | 2018 | 1 | 0.620 |
Why?
|
| Dilatation | 1 | 2018 | 48 | 0.610 |
Why?
|
| Otitis | 1 | 2018 | 2 | 0.610 |
Why?
|
| Ear, Middle | 2 | 2020 | 26 | 0.600 |
Why?
|
| Ciprofloxacin | 1 | 2018 | 29 | 0.600 |
Why?
|
| Craniotomy | 1 | 2018 | 89 | 0.600 |
Why?
|
| Stapes | 2 | 2015 | 8 | 0.600 |
Why?
|
| Endolymphatic Sac | 1 | 2017 | 2 | 0.590 |
Why?
|
| Hearing Loss, Bilateral | 2 | 2009 | 10 | 0.590 |
Why?
|
| Migraine Disorders | 1 | 2018 | 40 | 0.580 |
Why?
|
| Child | 15 | 2020 | 7240 | 0.580 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2017 | 17 | 0.580 |
Why?
|
| Middle Aged | 24 | 2021 | 26146 | 0.570 |
Why?
|
| Vestibular Nerve | 1 | 2017 | 33 | 0.560 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 78 | 0.560 |
Why?
|
| Retrospective Studies | 16 | 2021 | 9210 | 0.560 |
Why?
|
| Speech Perception | 3 | 2020 | 72 | 0.550 |
Why?
|
| Fistula | 1 | 2017 | 42 | 0.540 |
Why?
|
| Treatment Outcome | 12 | 2021 | 8273 | 0.540 |
Why?
|
| Bone Conduction | 2 | 2013 | 5 | 0.530 |
Why?
|
| Branchio-Oto-Renal Syndrome | 1 | 2016 | 4 | 0.530 |
Why?
|
| Osseointegration | 2 | 2013 | 11 | 0.530 |
Why?
|
| Ear Ossicles | 2 | 2013 | 10 | 0.530 |
Why?
|
| Male | 28 | 2021 | 42674 | 0.520 |
Why?
|
| Skull Neoplasms | 1 | 2016 | 30 | 0.520 |
Why?
|
| Tympanoplasty | 2 | 2012 | 13 | 0.520 |
Why?
|
| Ossification, Heterotopic | 1 | 2016 | 33 | 0.510 |
Why?
|
| Periosteum | 1 | 2015 | 10 | 0.510 |
Why?
|
| Malleus | 2 | 2012 | 4 | 0.510 |
Why?
|
| Adult | 21 | 2021 | 26816 | 0.500 |
Why?
|
| Cranial Sinuses | 1 | 2015 | 15 | 0.500 |
Why?
|
| Glucocorticoids | 3 | 2018 | 357 | 0.500 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 272 | 0.490 |
Why?
|
| Nanocapsules | 1 | 2015 | 11 | 0.490 |
Why?
|
| Indocyanine Green | 1 | 2015 | 22 | 0.480 |
Why?
|
| Rhabdomyosarcoma | 1 | 2015 | 42 | 0.480 |
Why?
|
| Hearing Loss, Unilateral | 2 | 2013 | 3 | 0.480 |
Why?
|
| Diverticulum | 1 | 2015 | 45 | 0.480 |
Why?
|
| Incus | 2 | 2012 | 2 | 0.480 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2017 | 2677 | 0.480 |
Why?
|
| Cadaver | 4 | 2019 | 186 | 0.470 |
Why?
|
| Female | 27 | 2021 | 46587 | 0.470 |
Why?
|
| Young Adult | 10 | 2021 | 6409 | 0.460 |
Why?
|
| Otitis Media | 2 | 2011 | 20 | 0.460 |
Why?
|
| Adolescent | 13 | 2019 | 9340 | 0.460 |
Why?
|
| Photochemotherapy | 1 | 2015 | 100 | 0.460 |
Why?
|
| Brain Diseases | 1 | 2015 | 186 | 0.450 |
Why?
|
| Ichthyosis, Lamellar | 1 | 2013 | 1 | 0.440 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 1255 | 0.420 |
Why?
|
| Laryngeal Diseases | 2 | 2004 | 21 | 0.420 |
Why?
|
| Antibodies | 1 | 2015 | 353 | 0.420 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 798 | 0.400 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 321 | 0.400 |
Why?
|
| Aging | 1 | 2017 | 727 | 0.400 |
Why?
|
| Aged | 17 | 2020 | 19254 | 0.390 |
Why?
|
| ErbB Receptors | 1 | 2015 | 499 | 0.380 |
Why?
|
| Triamcinolone Acetonide | 1 | 2011 | 8 | 0.380 |
Why?
|
| Nasal Sprays | 1 | 2011 | 9 | 0.380 |
Why?
|
| Stapes Mobilization | 1 | 2011 | 1 | 0.370 |
Why?
|
| Prosthesis-Related Infections | 1 | 2011 | 61 | 0.370 |
Why?
|
| Child, Preschool | 8 | 2019 | 3771 | 0.360 |
Why?
|
| Reoperation | 4 | 2020 | 604 | 0.350 |
Why?
|
| Cochlea | 3 | 2020 | 50 | 0.330 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 1055 | 0.320 |
Why?
|
| Auditory Threshold | 3 | 2018 | 15 | 0.300 |
Why?
|
| Spiral Ganglion | 2 | 2018 | 25 | 0.300 |
Why?
|
| Chronic Disease | 3 | 2018 | 958 | 0.270 |
Why?
|
| Keratitis | 1 | 2006 | 22 | 0.260 |
Why?
|
| Vestibular Diseases | 1 | 2006 | 28 | 0.260 |
Why?
|
| Parotid Diseases | 1 | 2005 | 5 | 0.250 |
Why?
|
| Hypopharynx | 1 | 2005 | 8 | 0.250 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2005 | 24 | 0.240 |
Why?
|
| Infant | 4 | 2019 | 3188 | 0.240 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 2004 | 18 | 0.230 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1744 | 0.230 |
Why?
|
| Tracheal Diseases | 1 | 2004 | 15 | 0.230 |
Why?
|
| Esophageal Diseases | 1 | 2004 | 27 | 0.230 |
Why?
|
| Hearing Tests | 2 | 2014 | 11 | 0.230 |
Why?
|
| Cysts | 1 | 2005 | 106 | 0.230 |
Why?
|
| Immunoglobulin A | 1 | 2004 | 83 | 0.230 |
Why?
|
| Biopsy | 2 | 2018 | 1184 | 0.230 |
Why?
|
| Dissection | 2 | 2015 | 44 | 0.220 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 2003 | 9 | 0.220 |
Why?
|
| Laryngostenosis | 1 | 2003 | 18 | 0.220 |
Why?
|
| Tympanic Membrane | 2 | 2013 | 13 | 0.210 |
Why?
|
| Tympanic Membrane Perforation | 2 | 2012 | 7 | 0.210 |
Why?
|
| Equipment Failure | 2 | 2013 | 122 | 0.200 |
Why?
|
| Sternoclavicular Joint | 1 | 2001 | 2 | 0.200 |
Why?
|
| Edema | 1 | 2001 | 70 | 0.190 |
Why?
|
| Dexamethasone | 2 | 2018 | 343 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2023 | 3475 | 0.180 |
Why?
|
| Neuroma, Acoustic | 1 | 2020 | 20 | 0.180 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 6783 | 0.170 |
Why?
|
| Tracheostomy | 1 | 2000 | 46 | 0.170 |
Why?
|
| Vertigo | 1 | 2020 | 41 | 0.170 |
Why?
|
| Anisotropy | 1 | 2019 | 63 | 0.160 |
Why?
|
| Cochlear Nerve | 1 | 2019 | 9 | 0.160 |
Why?
|
| Biocompatible Materials | 1 | 2020 | 198 | 0.160 |
Why?
|
| Postoperative Care | 1 | 2000 | 231 | 0.160 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 1 | 2018 | 12 | 0.160 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2018 | 37 | 0.160 |
Why?
|
| Betahistine | 1 | 2018 | 1 | 0.150 |
Why?
|
| Triamterene | 1 | 2018 | 1 | 0.150 |
Why?
|
| Middle Ear Ventilation | 1 | 2018 | 4 | 0.150 |
Why?
|
| Magnesium Oxide | 1 | 2018 | 4 | 0.150 |
Why?
|
| Skull Base | 1 | 2018 | 48 | 0.150 |
Why?
|
| Electric Impedance | 1 | 2018 | 111 | 0.150 |
Why?
|
| Hydrochlorothiazide | 1 | 2018 | 41 | 0.150 |
Why?
|
| Patient Selection | 2 | 2012 | 682 | 0.150 |
Why?
|
| Treatment Failure | 1 | 2018 | 278 | 0.150 |
Why?
|
| Drug Combinations | 1 | 2018 | 203 | 0.150 |
Why?
|
| Head and Neck Neoplasms | 1 | 2005 | 1061 | 0.150 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2018 | 151 | 0.140 |
Why?
|
| Vasodilator Agents | 1 | 2018 | 145 | 0.140 |
Why?
|
| Hair Cells, Auditory | 1 | 2017 | 24 | 0.140 |
Why?
|
| Fatal Outcome | 1 | 2017 | 296 | 0.140 |
Why?
|
| Cell Count | 1 | 2017 | 199 | 0.140 |
Why?
|
| Combined Modality Therapy | 2 | 2015 | 1704 | 0.140 |
Why?
|
| Syndrome | 2 | 2009 | 450 | 0.140 |
Why?
|
| Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2016 | 2 | 0.130 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 3678 | 0.130 |
Why?
|
| Surveys and Questionnaires | 3 | 2011 | 2655 | 0.130 |
Why?
|
| Temporal Muscle | 1 | 2015 | 12 | 0.130 |
Why?
|
| Action Potentials | 1 | 2018 | 601 | 0.120 |
Why?
|
| Keratinocytes | 1 | 2015 | 146 | 0.110 |
Why?
|
| Second-Look Surgery | 1 | 2013 | 4 | 0.110 |
Why?
|
| Postoperative Period | 1 | 2014 | 301 | 0.110 |
Why?
|
| Preoperative Care | 1 | 2016 | 395 | 0.110 |
Why?
|
| Risk Factors | 3 | 2013 | 5558 | 0.110 |
Why?
|
| Prognosis | 2 | 2015 | 3798 | 0.110 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 996 | 0.110 |
Why?
|
| Radiography | 1 | 2015 | 808 | 0.110 |
Why?
|
| Glomus Jugulare Tumor | 1 | 2012 | 2 | 0.100 |
Why?
|
| Carotid Body Tumor | 1 | 2012 | 3 | 0.100 |
Why?
|
| Cranial Nerve Diseases | 1 | 2012 | 8 | 0.100 |
Why?
|
| Polyvinyls | 1 | 2012 | 17 | 0.100 |
Why?
|
| Spiral Lamina | 1 | 2011 | 2 | 0.100 |
Why?
|
| Meningitis | 1 | 2011 | 21 | 0.100 |
Why?
|
| Geniculate Ganglion | 1 | 2011 | 2 | 0.100 |
Why?
|
| Telephone | 1 | 2011 | 36 | 0.100 |
Why?
|
| Fibrosis | 1 | 2012 | 236 | 0.090 |
Why?
|
| Suture Anchors | 1 | 2010 | 5 | 0.090 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 300 | 0.090 |
Why?
|
| Logistic Models | 2 | 2012 | 1214 | 0.090 |
Why?
|
| Placebos | 1 | 2011 | 211 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 305 | 0.090 |
Why?
|
| Pediatrics | 1 | 2015 | 360 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 358 | 0.090 |
Why?
|
| Endoscopy | 1 | 2013 | 352 | 0.090 |
Why?
|
| Surgical Wound Infection | 1 | 2011 | 202 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2006 | 1606 | 0.080 |
Why?
|
| Embolization, Therapeutic | 1 | 2012 | 265 | 0.080 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 2000 | 0.080 |
Why?
|
| Speech Intelligibility | 1 | 2009 | 10 | 0.080 |
Why?
|
| Retinal Artery Occlusion | 1 | 2009 | 12 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2018 | 4329 | 0.070 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 460 | 0.070 |
Why?
|
| Double-Blind Method | 1 | 2011 | 1714 | 0.070 |
Why?
|
| Chlorambucil | 1 | 2005 | 23 | 0.060 |
Why?
|
| Dapsone | 1 | 2004 | 10 | 0.060 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2004 | 65 | 0.060 |
Why?
|
| Esophagoscopy | 1 | 2004 | 90 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2010 | 2886 | 0.060 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2003 | 21 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2005 | 569 | 0.050 |
Why?
|
| Catheterization | 1 | 2004 | 237 | 0.050 |
Why?
|
| Respiratory Insufficiency | 1 | 2004 | 162 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2001 | 67 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2004 | 346 | 0.050 |
Why?
|
| Neurofibromatosis 2 | 1 | 2020 | 11 | 0.040 |
Why?
|
| Otolaryngology | 1 | 2000 | 55 | 0.040 |
Why?
|
| Acoustic Impedance Tests | 1 | 2018 | 3 | 0.040 |
Why?
|
| Data Collection | 1 | 2000 | 377 | 0.040 |
Why?
|
| Telemetry | 1 | 2018 | 36 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2004 | 2497 | 0.040 |
Why?
|
| Evoked Potentials | 1 | 2019 | 191 | 0.040 |
Why?
|
| Time Factors | 1 | 2006 | 5358 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 2331 | 0.030 |
Why?
|
| Ear Cartilage | 1 | 2012 | 4 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2011 | 785 | 0.020 |
Why?
|
| United States | 1 | 2000 | 7108 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 2327 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 1913 | 0.010 |
Why?
|